What is the main objective of the joint research between DUMSCO and Kansai Medical University?

The main objective is to establish more effective ePRO operation guidelines and build foundational information to contribute to future system improvements by analyzing Hakarute usage data.

What is the specific research period for this joint study?

The joint research is scheduled to take place from December 1, 2025, to March 31, 2027.

What is the title of the retrospective study being conducted?

The research title is "Retrospective study on the usage status of e-PRO (electronic Patient Reported Outcome) for patients receiving anticancer drug therapy."

Who are the key members involved in this joint research system?

The research system includes Professor Masashi Kanai and Assistant Professor Kohei Nagata from Kansai Medical University, alongside Director Naofumi Wakabayashi from DUMSCO.

What are the challenges in implementing ePRO in clinical settings in Japan?

The challenges in clinical settings in Japan include addressing elderly patients, operational burden, and insufficient detailed analysis of which patient groups and items function effectively.

AI News NQ Analysis

DUMSCO Commences Joint Research with Kansai Medical University on the Actual Usage of ePRO 'Hakarute'

NQ Score 50/100

AI Summary (NQ-processed)

DUMSCO and Kansai Medical University have begun joint research on the actual usage of the ePRO system 'Hakarute'.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the main objective of the joint research between DUMSCO and Kansai Medical University?: A: The main objective is to establish more effective ePRO operation guidelines and build foundational information to contribute to future system improvements by analyzing Hakarute usage data.
Q: What is the specific research period for this joint study?: A: The joint research is scheduled to take place from December 1, 2025, to March 31, 2027.
Q: What is the title of the retrospective study being conducted?: A: The research title is "Retrospective study on the usage status of e-PRO (electronic Patient Reported Outcome) for patients receiving anticancer drug therapy."
Q: Who are the key members involved in this joint research system?: A: The research system includes Professor Masashi Kanai and Assistant Professor Kohei Nagata from Kansai Medical University, alongside Director Naofumi Wakabayashi from DUMSCO.
Q: What are the challenges in implementing ePRO in clinical settings in Japan?: A: The challenges in clinical settings in Japan include addressing elderly patients, operational burden, and insufficient detailed analysis of which patient groups and items function effectively.